Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
BioPharmaceutical

U.K. drug approval secret is out

  • News

Executive Summary

Advertisements for medicines in U.K. will be able to describe the product as Medicines and Healthcare products Regulatory Agency "approved" following incorporation of European Directive 2001/83/EC into U.K. legislation in October 2005. Under current U.K. regulation, an advertisement "should not refer to the fact that a medicine is licensed, either directly or indirectly," MHRA's updated 1"Blue Guide" on advertising and promotion of medicines in the U.K. states...

Table

View full table

Topics

Tags:
BioPharmaceutical
Latest Headlines

Bolar Exemption India Files: Roche Blocks Alleged Infringer Of Evrysdi Patent

First Do No Harm: US MedPAC Wrestles With Complexity Of Low-Cost Drug Pricing

JNJ, BMS’s IRA Loss Is First Time Court Rejects Industry’s First Amendment, Takings Claims

EU Launches Critical Medicines Alliance But Prospect Of Act On Manufacturing Still Uncertain

See All
UsernamePublicRestriction

Register

PS045450

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By